Vaxcyte, Inc.PCVXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+48.1%
5Y CAGR+54.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+48.1%/yr
vs +64.9%/yr prior
5Y CAGR
+54.7%/yr
Recent deceleration
Acceleration
-16.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
8.9x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$129.37M+39.3%
2024$92.90M+53.1%
2023$60.70M+52.5%
2022$39.81M+57.6%
2021$25.26M+72.9%
2020$14.61M+99.8%
2019$7.31M+35.7%
2018$5.39M+6.7%
2017$5.05M-